Ignite Creation Date:
2024-05-06 @ 8:29 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06398587
Status:
WITHDRAWN
Last Update Posted:
2024-05-03
First Post:
2024-04-30
Brief Title:
Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced Unresectable or Metastatic Pancreatic Ductal Adenocarcinoma
Sponsor:
OHSU Knight Cancer Institute
Organization:
OHSU Knight Cancer Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-05-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-06-07
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-30
First Submit QC Date:
April 30 2024
Study First Post Date:
2024-05-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-17
Last Update Post Date:
2024-05-03
Last Update Post Date Type:
ACTUAL